Cullen/Frost Bankers’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
EAM
VCM
Cullen/Frost Bankers's COLL Position: Q1 2026 in Review
Cullen/Frost Bankers increased its Collegium Pharmaceutical (COLL) stake by 12% in Q1 2026, buying an estimated $1.69K and bringing the position to 362 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.
Cullen/Frost Bankers first reported a position in COLL in Q4 2025 and has held it in 2 quarters since. The position peaked at $14.9K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Cullen/Frost Bankers held 362 shares of Collegium Pharmaceutical worth $12K as of Q1 2026.
- Cullen/Frost Bankers bought 40 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.69K.
- Collegium Pharmaceutical made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #1077 holding.
- Cullen/Frost Bankers first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
- Cullen/Frost Bankers's Collegium Pharmaceutical position peaked at $14.9K in Q4 2025.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.